AU7009600A - Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes - Google Patents

Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes

Info

Publication number
AU7009600A
AU7009600A AU70096/00A AU7009600A AU7009600A AU 7009600 A AU7009600 A AU 7009600A AU 70096/00 A AU70096/00 A AU 70096/00A AU 7009600 A AU7009600 A AU 7009600A AU 7009600 A AU7009600 A AU 7009600A
Authority
AU
Australia
Prior art keywords
dendritic cells
resulting
obtaining
clinical purposes
clinical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70096/00A
Other languages
English (en)
Inventor
Bernard Klein
Karin Tarte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CELLGEN SARL
Centre Hospitalier Universitaire
Original Assignee
CELLGEN SARL
Centre Hospitalier Universitaire de Montpellier CHUM
Centre Hospitalier Universitaire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CELLGEN SARL, Centre Hospitalier Universitaire de Montpellier CHUM, Centre Hospitalier Universitaire filed Critical CELLGEN SARL
Publication of AU7009600A publication Critical patent/AU7009600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU70096/00A 1999-07-29 2000-07-28 Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes Abandoned AU7009600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR99/09836 1999-07-29
FR9909836A FR2796961B1 (fr) 1999-07-29 1999-07-29 Procede d'obtention de cellules dentritiques, les cellules dentritiques ainsi obtenues et leurs utilisations a des fins cliniques
PCT/FR2000/002173 WO2001009288A1 (fr) 1999-07-29 2000-07-28 Procede d'obtention de cellules dendritiques, les cellules dendritiques ainsi obtenues et leurs utilisations a des fins cliniques

Publications (1)

Publication Number Publication Date
AU7009600A true AU7009600A (en) 2001-02-19

Family

ID=9548651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70096/00A Abandoned AU7009600A (en) 1999-07-29 2000-07-28 Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes

Country Status (4)

Country Link
EP (1) EP1198558A1 (fr)
AU (1) AU7009600A (fr)
FR (1) FR2796961B1 (fr)
WO (1) WO2001009288A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL375035A1 (en) * 2002-06-19 2005-11-14 Northwest Biotherapeutics, Inc. Tangential flow filtration devices and methods for leukocyte enrichment
AT412145B (de) * 2002-09-13 2004-10-25 Forsch Krebskranke Kinder Verfahren zur herstellung eines zellulären immuntherapeutikums auf basis von il-12-freisetzenden dendritischen zellen
EP1484064A1 (fr) * 2003-06-04 2004-12-08 Gesellschaft für Biotechnologische Forschung Composition thérapeutique contenant des cellules dendritiques et son utilisation
DE102007006736B4 (de) 2007-02-07 2012-01-12 Dagmar Briechle In-vitro Testkit zur tierversuchsfreien Bestimmung des sensibilisierenden Potentials einer Substanz
CN115433714A (zh) * 2022-04-15 2022-12-06 广东汉氏干细胞生物科技有限公司 一种免疫细胞在治疗疾病中的应用及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983345A1 (fr) * 1997-05-21 2000-03-08 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Procedes et compositions permettant d'obtenir des cellules dendritiques a partir de populations amplifiees de monocytes, et d'activer les cellules t

Also Published As

Publication number Publication date
WO2001009288A1 (fr) 2001-02-08
EP1198558A1 (fr) 2002-04-24
FR2796961A1 (fr) 2001-02-02
FR2796961B1 (fr) 2003-05-02

Similar Documents

Publication Publication Date Title
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
EP1115166A4 (fr) Separateur de cellule, cellule, et procede de production dudit separateur
AU5731400A (en) Methods of preparing electrochemical cells
AU1796601A (en) Methods of preparing electrochemical cells
AU3746200A (en) Tin-clad substrates for use as current collectors, batteries comprised thereof and methods for preparing same
AU2003246159A1 (en) Nobonene-ester based addition polymer and method for preparing the same
AU7644600A (en) Method and device for producing solar cells
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU1796501A (en) Methods of preparing electrochemical cells
AU2308900A (en) Analysis method
AU2001266127A1 (en) Method for obtaining characterised muscle-derived cell populations and uses
AU1409700A (en) Method for counting living cells
AU7009600A (en) Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes
AU7428100A (en) Method for obtaining water soluble polymers, resulting polymers and uses thereof
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001271926A1 (en) Methods for promoting dendritic cell proliferation or differentiation
AU4771600A (en) Cells, culture methods and their uses
AUPQ314799A0 (en) Bone cell factor
AU2268099A (en) Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof
AU2221401A (en) Straw attaching method, and straw attaching device
AU2194801A (en) Diagnostic method
AU6000600A (en) Diagnostic method
AU3440700A (en) Assays, methods and means
AU6835500A (en) Tissue substitute and method for the production thereof
AU2830401A (en) Amphiphilic polyamines, the use and method for synthesis thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 21, PAGE(S) 4494-4498 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 51465/99, 64890/99, 64891/99, 22951/00, 59659/00, 61761/00, 62537/00, 62720/00, 62911/00, 62983/00, 64395/00, 65663/00, 67057/00, 67058/00, 68327/00, 68469/00, 68477/00, 68483/00, 68490/00, 70093/00, 70094/00, 70096/00, 70098/00, AND 15446/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase